(Q44058307)

English

An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry (English)

1 reference

Europe PubMed Central

29 November 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Diana Safarian

1

1 reference

Europe PubMed Central

29 November 2017

Xavier Carnec

2

1 reference

Europe PubMed Central

29 November 2017

Fotini Tsamis

3

1 reference

Europe PubMed Central

29 November 2017

Francis Kajumo

4

1 reference

Europe PubMed Central

29 November 2017

Tatjana Dragic

5

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

14 June 2006

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

352

1 reference

Europe PubMed Central

29 November 2017

2

1 reference

Europe PubMed Central

29 November 2017

477-484

1 reference

Europe PubMed Central

29 November 2017

Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Human Immunodeficiency Virus Type 1 Env with an Intersubunit Disulfide Bond Engages Coreceptors but Requires Bond Reduction after Engagement To Induce Fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Novel alleles of the chemokine-receptor gene CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

V3: HIV's switch-hitter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

HIV fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.05.016

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44058307&oldid=2106111959"